Loading...

Genetic Testing And Global Launches Will Expand Rare Disease Access

Published
29 Aug 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
60.5%
7D
4.9%

Author's Valuation

US$8919.7% undervalued intrinsic discount

AnalystHighTarget Fair Value